Zacks Investment Research on MSN1h
GILD Stock Down on Report of Cut in HIV Prevention Spending
Shares of Gilead Sciences, Inc. GILD were down 2.47% after the Wall Street Journal reported that The Health and Human ...
Investor's Business Daily on MSN1d
Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding
Gilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' ...
Fierce Healthcare1d
HHS may cut HIV prevention efforts at the CDC. Advocates fear changes will spike infections
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the ...
The Lancet9d
The potential for annual long-acting HIV pre-exposure prophylaxis
Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...
KESQ20h
DAP Health joins health organizations to condemn plans to close CDC’s HIV prevention division
DAP Health was one of 13 of the nation's leading LGBTQ+, HIV, and health organizations that united to condemn the Trump ...
Medscape7d
Antiretrovirals Alone Don’t Delay Language Development in Exposed Children
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...
The Washington Informer20h
Leading LGBTQ, HIV, and Health Organizations Across U.S. Condemn Trump Administration’s Move to Close CDC HIV Prevention Division
Thirteen LGBTQ+, HIV, and health organizations unite to raise awareness about Trump administration's planned cuts to CDC HIV ...
Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts
Oppenheimer notes that Gilead (GILD) shares are weak today following reports from multiple media outlets that the Health and Human Services ...